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Abstract VacA is a major virulence factor of the widespread
stomach-dwelling bacterium Helicobacter pylori. It causes cell
vacuolation and tissue damage by forming anion-selective, urea-
permeable channels in plasma and endosomal membranes. We
report that several £avone derivatives and other polyphenols
present in vegetables and plants inhibit ion and urea conduction
and cell vacuolation by VacA. Red wine and green tea, which
contain many of the compounds in question, also potently inhibit
the toxin. These observations suggest that polyphenols or poly-
phenol derivatives may be useful in the prevention or cure of
H. pylori-associated gastric diseases.
# 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Infection by the stomach-dwelling bacterium Helicobacter
pylori [1,2] constitutes a major risk factor for gastritis, peptic
ulcer, gastric cancer and mucosa-associated lymphoid tissue
lymphoma. Some epidemiological studies have indicated a
correlation between H. pylori seropositivity and environmen-
tal factors, including the diet: a lower incidence of infection
has been associated with the consumption of vegetables (e.g.
[3]), wine [4] and green tea [5].
The secreted vacuolating cytotoxin VacA [2,6,7] can directly
induce gastric epithelial damage in mice upon intragastric or
oral administration [8,9], and it is believed to play an impor-
tant role in the aetiology of ulcers. While vacA3 H. pylori
strains grow well under laboratory conditions, and are able
to infect animals, VacA confers a strong advantage during
colonisation of the stomach in a mouse model and in com-
petition against isogenic, vacA3 strains [10].
VacA forms oligomeric, anion-selective, urea-permeable
channels in arti¢cial and plasma membranes [11^14]. Urea
conduction may well be the most relevant function of the
toxin for H. pylori, which depends on urea supplied by the
epithelium and hydrolysed by the bacterium’s urease to bu¡er
the pH in and around the cell. VacA owes its name to its
ability to cause vacuolation of cultured cells [15,16] if acti-
vated by exposure to acid or basic pH. The vacuoles, whose
formation is strongly assisted by the presence of permeant
amines, originate from late endosomal^lysosomal compart-
ments [17]. We have proposed that VacA causes vacuolation
because upon endocytosis it increases the permeability to
anions of the membrane of late endosomes. This in turn
causes depolarisation, increased Hþ pumping into the lumen
by V-ATPase, accumulation of NH4Cl and osmotically driven
water in£ux and swelling [18], possibly accompanied by mem-
brane fusion events. Our previous studies have identi¢ed a set
of inhibitors of VacA activities, the most powerful of which
are 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB) and
phloretin (KD 18 and 15 WM respectively in planar bilayer
experiments) [14,19,20].
We noticed structural similarities between VacA inhibitors
such as 4,4P-diisothiocyanatostilbene-2,2P-disulphonic acid,
NPPB and phloretin and some plant phenolic compounds,
i.e. the most numerous and widespread class of phytochemi-
cals: £avones, iso£avones, £avo- and £avanols, anthocyani-
dins, tannins and stilbene derivatives. They are present in var-
iable amounts in many foods of vegetal origin, including wine
and green tea. Several show anti-oxidant, anti-tumorigenic,
anti-in£ammatory and other medically relevant activities,
and induce death and/or proliferation arrest in immortalised,
tumour-derived cell lines (e.g. [21^24]). Because of these sim-
ilarities, and of the reports of a relevance of the diet for H.
pylori infection and gastric disease, we investigated whether
red wine and green tea, both rich in £avonoids, catechins and
tannins, as well as several representative polyphenols, acted as
inhibitors of VacA.
2. Materials and methods
2.1. Toxin
The VacA isoform used was the s1/m1-type produced by strain
CCUG 17874, isolated as previously described [25].
2.2. Inhibitors
Fig. 1 presents the polyphenols used in this study. They were pur-
chased from Sigma (Milan, Italy) unless otherwise indicated. Stock
solutions were prepared in dimethyl sulphoxide except for tannic acid
(in ethanol).
Wines (vintage 2000) were produced on a local family vineyard by
the traditional spontaneous fermentation process. No additives were
used. The green tea solution was obtained by boiling 2 g of lyophilised
and otherwise untreated leaves in 1 l of distilled water for 5 min. The
extract was concentrated by evaporation under vacuum at 30‡C.
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Ethanol-free red and white wine concentrates were obtained in the
same way. The volume fractions mentioned below and in the ¢gures
(e.g. 1:10) refer to (equivalent) concentrations of the original liquid,
calculated on the basis of the concentration factor of the concentrate
used.
2.3. Cell culture
HeLa cells were grown at 37‡C in plastic £asks in Dulbecco’s modi-
¢ed Eagle’s medium plus foetal calf serum (10%, v/v), penicillin (100
U/ml) and streptomycin (100 Wg/ml) in a 5% CO2 atmosphere.
2.4. Electrophysiology
Planar bilayer experiments were conducted essentially as previously
described [11]. Diphytanoylphosphatidylcholine (synthetic; Avanti
Polar Lipids, Alabaster, AL, USA; purity s 99%) was the membrane
lipid. The standard medium was symmetrical 500 mM KCl, 0.5 mM
CaCl2, 0.5 mM MgCl2, 10 mM HEPES/Kþ, pH 7.2. For experiments
involving acidi¢cation, 10 mM citrate was also present. The toxin and
inhibitors were added into the compartment (cis) containing the active
electrode, whose voltage is reported with reference to the grounded
electrode in trans. A current (cations) £owing from cis to trans is
de¢ned as positive. To verify the reversibility of inhibition the cis
compartment was perfused with fresh medium (a seven-fold larger
volume). Titration data (each point the average of three to ¢ve inde-
pendent determinations) were ¢tted using the relationship %r:c: =
1003P1/(1+KD/[L]) [19], a form of the Langmuir isotherm, in which
%r:c: stands for the per cent residual current, [L] is the concentration
of inhibitor, and P1 is a ¢tting parameter, whose physical meaning is
the maximal percentage of inhibition theoretically observable at an
in¢nite concentration of inhibitor. The toxin was added after preacti-
vation at 37‡C, pH 2.0 for 5^8 min. Inhibitors were added after the
current level had reached a plateau. Whole-cell patch-clamp experi-
ments were conducted on HeLa cells, exposed or not to pre-activated
VacA, essentially as described in [13]. The inhibitor was added using a
pipette, and the chamber contents were thoroughly mixed by with-
drawing and re-adding a fraction of the medium several times.
2.5. Vacuolation
Vacuolation assays were performed as described in [13]. The e¡ects
of the toxin and of the various inhibitors were documented by photo-
graphs and using the Neutral red uptake method [16].
2.6. Urea permeation
Assays were conducted using cultured HeLa cells, following the
transmembrane £ux of [14C]urea (45 WM; 57 mCi/mmol; Amersham
Pharmacia Biotech, UK) essentially as described in [14]. The kinetics
of urea e¥ux from pre-loaded cells were determined over a 30-min
period after washing with phosphate-bu¡ered saline containing the
desired substances by liquid scintillation counting of samples taken
at predetermined intervals. The inhibitory e¡ects are expressed as the
per cent inhibition of the increase of urea e¥ux induced by the toxin
alone with respect to that of cells treated with no toxin.
3. Results
Red wine and green tea concentrates dramatically reduced
current conduction by VacA in planar bilayer experiments
(Fig. 2A,C,D). The addition to both bilayer chambers of
enough concentrate to make the medium equivalent to a
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Fig. 1. Structures of the polyphenols used in this study. The com-
pounds are arranged in the same order as in Table 1. 1: Apigenin
(4P,5,7-trihydroxy£avone) (Fluka, Milan, Italy). 2: Baicalein (5,6,7-
trihydroxy£avone) (Aldrich, Milan, Italy). 3: Chrysin (5,7-dihy-
droxy£avone) (Fluka). 4: Myricetin (3,3P,4P,5,5P,7-hexahydroxy£a-
vone) (Fluka). 5: Morin (2P,3,4P,5,7-pentahydroxy£avone) (Riedel-
de-Haen, Milan, Italy). 6: Quercetin (3,3P,4P,5,7-pentahydroxy£a-
vone). 7: Genistein (4P,5,7-trihydroxyiso£avone). 8: Catechin (3,3P,
4P,5,7-£avanpentol). 9: Epicatechin ([2R,3R]-2-[3,4-dihydroxyphenyl]-
3,4-dihydro-1[2H]-benzopyran-3,5,7-triol). 10: Epicatechin gallate
([2R,3R]-2-[3,4-dihydroxyphenyl]-3,4-dihydro-1[2H]-benzopyran-3,5,7-
triol 3-[3,4,5-trihydroxybenzoate]). 11: Epigallocatechin ([2R,3R]-
2-[3,4,5-trihydroxyphenyl]-3,4-dihydro-1[2H]-benzopyran-3,5,7-triol).
12: Epigallocatechin gallate ([2R,3R]-2-[3,4,5-trihydroxyphenyl]-3,4-
dihydro-1[2H]-benzopyran-3,5,7-triol 3-[3,4,5-trihydroxybenzoate]).
13: Piceatannol (3,3P,4,5P-tetrahydroxy-trans-stilbene). 14: Resvera-
trol (3,4P,5-trihydroxy-trans-stilbene). 15: Nordihydroguaiaretic acid
(1,4-bis[3,4-dihydroxyphenyl]-2,3-dimethylbutane). 16: Phloretin (3-
[4-hydroxyphenyl]-1-[2,4,6-trihydroxyphenyl]-1-propanone). 17: n-
Propylgallate (n-propyl-3,4,5-trihydroxybenzoate). 18: p-Rosolic acid
(4-[bis(4-hydroxyphenyl)methylene]-2,5-cyclohexadienone (Riedel-de-
Haen). 19: Tannic acid (Riedel-de-Haen) (a mixture of compounds,
mainly polygalloylglucoses; an average MW of 1700 was assumed
for calculations). 20: Phloridzin (phloretin 2P-O-L-D-glucoside). 21:
Rhapontin (4P-methoxy-3,3P,5-stilbenetriol 3-O-glucoside). 22: Rhoi-
folin (apigenin 7-O-neoesperidoside). 23: Rutin (3,3P,4P,5,7-pentahy-
droxy£avone 3-O-rutinoside). 24: Ellagic acid (4,4P,5,5P,6,6P-hexahy-
drodiphenic acid 2,6,2P,6P-dilactone) (Fluka). 25: Emodin (1,3,8-
trihydroxy-6-methyl-9,10-anthracenedione) (Fluka). 26: Esculetin
(6,7-dihydroxycoumarin) (Fluka). 27: Phloroglucinol (1,3,5-trihy-
droxybenzene) (Fluka).
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10% solution of red wine or tea was su⁄cient to reduce the
current by 75U 2% and 45U3% respectively. White wine was
less e¡ective by a factor of about 6, in line with a similarly
lower average content of polyphenolic compounds [26]. Anal-
ogous results were obtained, as expected [13], in patch-clamp
experiments on VacA-intoxicated HeLa cells (Fig. 2B). Since
wine and tea are complex mixtures, inhibition may show com-
plex features, as in the titration curve with green tea (Fig.
2D).
Lowering the pH of the experimental medium in both
chambers of the bilayer apparatus, either before or after the
addition of wine or tea concentrate, did not detectably in£u-
ence the extent of inhibition at least in the range 7^4 (not
shown). Bilayer experiments with a series of plant polyphenols
and structurally related molecules upheld the hypothesis that
the inhibitory e¡ects of wine and tea are to be attributed to
their content of compounds of this type (e.g. [26]). For each of
the compounds listed in Table 1, titration curves similar to the
ones in Fig. 3A were determined, and inhibition parameters
(Table 1) were obtained by ¢tting the curves as described in
Section 2.
In some cases the solubility of the polyphenol was the fac-
tor limiting the extent of inhibition as re£ected in the corre-
sponding entries in Table 1. We tested a few soluble glycosy-
lated derivatives, all of which however proved less e¡ective
than the parent aglycones. To verify whether the inhibitory
e¡ects may be linked to the anti-oxidant properties of some of
the compounds, we tested ascorbate, L-mercaptoethanol, di-
amide, dithiothreitol, p-chloromercuribenzenesulphonate and
CdCl2. All these redox or SH group reagents were completely
ine¡ective (not shown). Inhibition by tea, wine and tannic
acid showed a biphasic time course, with a rapid initial phase
followed by a slower inhibitory process, which could not be
reversed by washing. The kinetics of inhibition by 5 WM tan-
nic acid are shown in Fig. 3B. The titrations by these agents
(Fig. 2C,D) re£ect essentially the rapid phase.
As expected [20], inhibition of current conduction was par-
alleled by inhibition of the passive urea transport mediated by
the toxin in a cultured cell model (Fig. 4). Polyphenols did not
inhibit H. pylori urease activity (not shown).
According to the current mechanistic model, inhibition of
VacA channels ought to be paralleled by inhibition of vacuo-
lation, provided the inhibitor can di¡use into the cell, so as to
act at the endosome level. While many of the compounds
tested caused a clearly observable inhibition of vacuolation
(not shown), quantitative determinations were made di⁄cult
by accompanying cell su¡erance and death. These e¡ects are
to be ascribed to the well-documented cytotoxicity of many
polyphenols for cells of tumoural origin. In the cases of mor-
in, catechin and tannic acid no e¡ect ^ either on vacuolation
or on cell survival ^ was detected. The reasons for this lack of
activity remain to be determined. Among possible causes may
be binding by serum components and/or the inability to per-
meate the cell membrane.
4. Discussion
A large literature describes an ever-increasing number of
activities by wine, tea and individual plant phenolics on cel-
lular processes, enzymes and channels. In many cases these
interactions have potential clinical signi¢cance. The results
reported here show that members of this family have an in-
hibitory e¡ect on VacA, a toxin known to play a role in H.
pylori colonisation and survival [10], and to cause epithelial
damage [8,9]. All compounds that inhibited Cl3 conduction
also impaired plasma membrane urea permeation induced by
VacA (Fig. 4). The two e¡ects showed a quantitative correla-
tion (Fig. 4B) despite the profound di¡erences in experimental
design, con¢rming that the same type of mechanism/structure
is responsible for the transmembrane transport of ions and
urea. Under these circumstances VacA inhibition may explain
a possible relevance of dietary habits for the incidence of
infection by H. pylori and of diseases such as gastritis and
ulcer. These pathologies are linked to the activity of the toxin
itself in the stomach. Ingestion of polyphenols may therefore
be expected to decrease the probability of their insurgence in
H. pylori-infected individuals and might also decrease in£am-
mation and erosion after onset of the disease.
A few of the molecules listed in Table 1 are more powerful
VacA inhibitors than NPPB, and exert their action at concen-
trations within the pharmacologically relevant range. The
mechanistic details of inhibition, which may vary from com-
pound to compound, remain to be investigated, and may be
complex. Some of the compounds may act after partitioning
into the membrane, in a manner similar to that proposed for
NPPB [20].
While the known properties of tannins and the kinetics of
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
  
  
    
 
 
 
 
 
 
     
 
   
Fig. 2. Inhibition of VacA-mediated current conduction by wine
and green tea concentrates. A,C,D: Bilayer experiments. V: 340
mV. A: Sample current traces. Red wine (RW) or green tea (GT)
concentrate was added to the cis chamber of the apparatus to give
concentrations equivalent to 1/10 (RW) or 1/5 (GT) of the original
solutions. B: A representative patch-clamp experiment on a HeLa
cell : current traces before and after addition of RW concentrate to
give an equivalent concentration of 1/10. The voltage was varied in
20-mV steps from 360 to +80 mV. C,D: Titration curves derived
from experiments analogous to those illustrated in A. b : red wine;
a : white wine; F : green tea. The abscissa gives the equivalent con-
centration of wine or tea, taking as 1 that of the original (uncon-
centrated) beverage.
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inhibition by tannic acid (Fig. 3B) may suggest that unspeci¢c
multiple interactions and reactions might (partly) account for
the inhibitory e¡ects of these complex molecules, a correlation
of structure and function suggests otherwise for the other
compounds investigated. The most e¡ective among the latter
include resveratrol (no. 14 in Fig. 1), morin (no. 4) and pi-
ceatannol (no. 13). They share a structural motif consisting of
two benzene rings, in a trans con¢guration with respect to a
connecting two-atom planar bridge, substituted with two hy-
droxyls on one ring and (at least) one on the other, in posi-
tions 5, 7 and 4P of the £avone skeleton (3, 5 and 4P of the
stilbene skeleton). Gallate moieties seem not to confer an ad-
vantage. Thus, e.g. myricetin (no. 5) is less powerful than
either morin (no. 4) or quercetin (no. 6). Some compounds
with other ring structures, e.g. ellagic acid (no. 24), proved
essentially ine¡ective, despite being aromatic compounds with
multiple hydroxyls. The conclusion seems warranted that
VacA inhibition by polyphenols is due to speci¢c, well-de¢ned
molecule^molecule interactions. Redox e¡ects are unlikely to
play a role, because no correlation is apparent between the
reducing power of the compounds tested and their e¡ective-
ness as VacA inhibitors, and because of the lack of e¡ect of
the redox compounds mentioned above (see Section 3).
Currently H. pylori-symptomatic patients are treated with a
proton pump inhibitor and two antibiotics. The success rate is
high, but novel approaches are needed because of side e¡ects,
re-infection and the emergence of resistant strains [27]. Poly-
phenols may provide such a novel approach. While, as men-
tioned, phenolics a¡ect many cellular functions, they have al-
ways been a component of human diet, with no harmful side
e¡ects even at high dosages. Studies report, for example, the
oral administration of up to 150 mg (0.44 mmol)/day of quer-
cetin to humans [28] and of 20 mg (0.09 mmol)/kg/day of
Table 1
Inhibition of the VacA channel by di¡erent polyphenols
Class Compound KD (WM) P1 IC50 (WM) [X]max (WM)a %inhib at [X]max
Flavones and £avonols Apigenin 6U 2 39U 3 ^ 100 37U 6
Baicalein 57U 14 94U 8 65 200 77U 6
Chrysin 29U 6 73U 7 63 100 59U 6
Morin 5.7U 0.3 96U 1 6.2 200 94U 2
Myricetin 18U 3 68U 4 50 200 67U 3
Quercetin 13U 2 85U 3 19 200 85U 4
Iso£avones Genistein 31U 5 101U 6 30 200 87U 6
Flavanols and derivatives Catechin 123U 15 81U 4 198 500 66U 4
EC ^ ^ ^ 300 13U 3
EC gallate 56U 3 93U 2 65 500 84U 3
EGC 367U 88 45U 6 ^ 500 26U 3
EGC gallate 53U 11 66U 3 166 500 61U 5
Stilbene derivatives Piceatannol 9.1U 0.4 96U 1 9.9 100 89U 2
Resveratrol 5.5U 0.7 97U 3 5.9 100 93U 1
Other e¡ective polyphenols NDGA 12U2 100 12 100 95U 1
Phloretin 16U 1 97U 2 17 200 91U 1
n-PG 153U 13 93U 4 178 500 72U 3
p-Rosolic acid 20U 1 100 20 200 95U 1
Tannic acid 2.7U 0.5 100U 1 2.7 100 99U 1
Glycosylated polyphenols Phloridzin 186U 27 84U 5 273 500 62U 2
Rhapontin 38U 5 85U 3 54 500 82U 4
Rhoifolin 67U 7 29U 1 ^ 500 25U 5
Rutin 68U 9 82U 3 106 500 74U 3
Ine¡ective polyphenols Ellagic acid ^ ^ ^ 200 6U 1
Emodin ^ ^ ^ 200 0
Esculetin ^ ^ ^ 200 2U 1
Phloroglucinol ^ ^ ^ 500 0
EC, epicatechin; EGC, epigallocatechin; NDGA, nordihydroguaiaretic acid; n-PG, n-propylgallate.
aHighest concentration tested.
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Fig. 3. The VacA channel is inhibited by several polyphenols. A:
Two examples of titrations of current conduction by VacA in planar
bilayer experiments. Conditions as in Fig. 2. b : Morin; a : Rha-
pontin. B: Kinetics of the inhibition of current conduction by 5 WM
tannic acid (see text for details).
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resveratrol to rats [29]. Since VacA is produced in the stom-
ach, complications associated with absorption of polyphenols
would be no obstacle to their possible pharmaceutical appli-
cation in this ¢eld. The toxin is inhibited by wine or tea
equally well at pH values near 7 or 4, the latter being lower
than the near-neutral pH believed to prevail near the stomach
mucosa, where H. pylori dwells [2]. Flavonoids and £avonoid
glycosides are thought to be chemically stable under the con-
ditions of the human stomach [30]. The persistence of inhibi-
tion by tannin in time (irreversibility) may also be important
in vivo, prolonging the e¡ect of a transient increase of its
concentration (e.g. after a meal).
VacA plays a role in infection [10] by H. pylori and possibly
in its survival in the stomach, but its inhibition would be
expected to be of little consequence for bacteria growing in
the laboratory in a nutrient-rich and neutral environment.
Besides hindering infection by the bacterium, polyphenols
may be expected to exert bene¢cial e¡ects by limiting erosion
of the gastric mucosa and the other biological e¡ects mediated
by the toxin. These aspects are currently under investigation.
In conclusion, we have shown that a group of natural,
easily available, bioactive, reputedly bene¢cial compounds in-
hibit one of the major factors accounting for the virulence and
pathogenicity of H. pylori. Their use as agents for therapy or
prevention deserves consideration.
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Fig. 4. Several polyphenols, wine and tea inhibit VacA-mediated
transmembrane urea £ux. A: Histogram showing the e¡ect of the
tested substances on the e¥ux of [14C]urea from cells exposed to
VacA. Compounds were used at a concentration of 200 WM except
for apigenin and chrysin (20 WM) and epicatechin gallate, epigallo-
catechin gallate and rutin (50 WM). Wines (RW, WW) and tea (GT)
were added at a ¢nal volume fraction of 0.1. B: Plot relating per
cent inhibition of urea £ux to per cent inhibition of current conduc-
tion by the various compounds. Dotted line: linear regression ¢t
(r-0.88). Data are the mean of at least four experiments and bars
represent U S.E.M.
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